Artificial intelligence continues to transform life sciences, from accelerating drug discovery to improving patient diagnostics and optimizing manufacturing. But with great power comes great responsibility and rising regulatory scrutiny. That’s where ISO/IEC 42001 comes in.
Published in December 2023, this international standard is the first global framework for managing AI systems responsibly. It’s designed to help organizations build, run, and continuously improve AI in a way that’s transparent, ethical, and aligned with existing quality systems.
So What’s the Big Deal?
ISO/IEC 42001 formalizes how companies should govern AI across its entire lifecycle. It covers everything from:
- Assessing and managing risks like bias or errors
- Ensuring data integrity and traceability
- Keeping audit trails that regulators and customers can trust
- Embedding continuous improvement into AI operations
In life sciences, where the use of AI is often tied directly to patient health and product quality, this standard provides a blueprint for doing the right thing before regulators tell you exactly how.
The Impact on Life Sciences
Regulatory trust: Global health regulators are ramping up their focus on AI. Having a certified AI governance framework builds confidence with agencies like the FDA, EMA, and MHRA. It signals you take quality, safety, and patient outcomes seriously.
Protecting product quality & patient safety: AI now impacts everything from selecting clinical trial candidates to automating production. A poorly governed model could introduce bias, overlook a critical defect, or make flawed recommendations. ISO 42001 provides guardrails to minimize these risks.
Faster time to market: Proactive AI governance can reduce delays during audits or submissions by showing that your systems meet internationally recognized standards. It shifts conversations from “Is this safe?” to “Show us your framework.”
Standing out in a crowded market: In a world where anyone can claim “AI-powered,” being able to back it up with ISO 42001 certification sets you apart. It tells customers, partners, and investors you’re serious about doing AI right.
New Developments: ISPE’s GAMP Guide on AI
In addition to ISO/IEC 42001, the International Society for Pharmaceutical Engineering (ISPE) has taken another crucial step to support AI governance in life sciences. The recent release of its GAMP Guide on Artificial Intelligence provides a practical framework specifically tailored for regulated industries like life sciences. This guide, which builds on the principles outlined in ISO/IEC 42001, is an essential resource for organizations looking to implement AI in a compliant, risk-managed way.
The GAMP Guide outlines the critical elements of AI system implementation, including how to validate AI systems and manage the lifecycle of these technologies within regulated environments. It addresses how to design AI systems that are not only effective but also meet the stringent regulatory expectations for safety and efficacy in life sciences.
For life science companies, combining the insights from ISO/IEC 42001 and the ISPE GAMP Guide can ensure that AI deployments align with global best practices while minimizing risk. These complementary frameworks will help you integrate AI seamlessly into quality management systems, ensuring consistent, high-quality results.
In Brief: The Bottom Line
For life sciences companies, ISO/IEC 42001 and the ISPE GAMP Guide on AI are more than just certifications or guidelines. They are strategic tools to:
- Strengthen AI quality and reliability
- Protect patients and uphold public trust
- Streamline compliance with evolving global regulations
- Stay ahead in a rapidly changing, digital market
If your organization is exploring or already deploying AI, these frameworks give you a clear roadmap to ensure that innovation doesn’t come at the expense of quality or patient outcomes.
Related Content
Commissioner Unveils Priorities for a New FDA
FDA Shares Approach to Regulating AI: What Life Science Companies Need to Know
The State of Generative AI In Life Sciences: New Market Research
Ready to unlock new opportunities and drive success? Schedule an Analyst Inquiry today to explore how the latest advancements in automation, AI, and industrial autonomy can transform your business.
Visit Axendia.com or follow us on LinkedIn for more insights and updates. Together, we’ll prepare your organization for a future of resilience, adaptability, and growth.
The opinions and analysis expressed in this post reflect the judgment of Axendia at the time of publication and are subject to change without notice. Information contained in this post is current as of publication date. Information cited is not warranted by Axendia but has been obtained through a valid research methodology. This post is not intended to endorse any company or product and should not be attributed as such.